Abbott Laboratories recalls ARCHITECT BNP Calibrators Ptoduct Usage: The ARCHITECT BNP Calibrators are for the calibration of the ARCHITECT iSystem…
- Recall date
- May 24, 2019
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- Z-2078-2019
- FDA classification
- Class III
- Brand / firm
- Abbott Laboratories
- Sold / distributed
- Worldwide Distribution - US Nationwide in the states of AK, AL, AR, AZ, CA, CO, CT, DE, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, NC, ND, NE, NH, NJ, NV, NY, OH, OK, PA, RI, SC, SD, TN, TX, UT, VA, VT, WA, WI, WV, WY. Distributed worldwide to ALGERIA, ANDORRA, AUSTRIA,…
Why it was recalled
Presence of a time dependent, stability drift in patient and control results returned from ARCHITECT BNP testing.
Class III means the product violates regulations but is not likely to cause harm.
What was recalled
ARCHITECT BNP Calibrators Ptoduct Usage: The ARCHITECT BNP Calibrators are for the calibration of the ARCHITECT iSystem when used for the quantitative determination of human Btype natriuretic peptide (BNP) in human EDTA plasma.
Get recall alerts
Free email alert whenever Abbott Laboratories has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Abbott Laboratories